PE: The Impact and Benefit of Physical Activity on Premature Ejaculation

Sponsor
Ankara Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02844998
Collaborator
(none)
120
3
18

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the relationship between physical activity and PE, and determine whether moderate physical activity might delay ejaculation time or be an alternative treatment for PE.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: physical activity
  • Drug: dapoxetine 30 mg on demand
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
The Impact and Benefit of Physical Activity on Premature Ejaculation: Results of a Prospective, Randomized, Placebo-controlled Trial
Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
May 1, 2016
Actual Study Completion Date :
Jul 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Dapoxetine 30 mg

Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand)

Drug: dapoxetine 30 mg on demand
Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries

Experimental: Moderate Running

Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. (Minimally active category)

Behavioral: physical activity
patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week

Sham Comparator: Sham-controlled

Patients who have sedentary life style will be advised those to walk (not running )at most 30 minutes for 5 days in a week. (Inactive category)

Behavioral: physical activity
patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week

Outcome Measures

Primary Outcome Measures

  1. Premature Ejaculation Diagnostic Tool (Total Score) [Baseline and 30 Days]

    Premature Ejaculation Diagnostic Tool (PEDT) includes five items; control, frequency, minimal stimulation, distress, and interpersonal difficulty. In this classification tool, equal to or less than scores 8 indicates no PE, scores 9 and 10 indicate possible PE, and scores equal or higher than 11 indicates PE. Total score is between 2 and 22.

  2. Intravaginal Ejaculatory Latency Time [Baseline and 30 Days]

    Duration determined by the sexual partner with stopwatch method, and <1 minute was considered as PE. (minimum/maximum scores were not possible)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Sexually active, heterosexual patients without regular physical activity or erectile dysfunction, and had a sexual partner for at least six months, and sexual intercourse at least twice a week
Exclusion Criteria:
  • Use of medications for endocrinological, metabolic, chronic systemic, or psychiatric diseases, use of alcohol or addictive substances, or use of drugs that might affect erection and ejaculation, presence of patients with Peyronie's disease, chronic prostatitis, urethritis, or active urinary tract infection, and absence of regular physical activity or previous treatment for premature ejaculation.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Ankara Training and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Muhammet Fatih Kilinc, M.D., Ankara Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT02844998
Other Study ID Numbers:
  • 5191
First Posted:
Jul 26, 2016
Last Update Posted:
Sep 29, 2017
Last Verified:
Sep 1, 2017
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by Muhammet Fatih Kilinc, M.D., Ankara Training and Research Hospital
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Group 1 Group 2 Sham-controlled
Arm/Group Description Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand) dapoxetine 30 mg on demand: Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. Physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week (To increase the physical activity level to "minimally active category or moderate physical activities [600-3,000 MET-min/week] according to IPAQ classification) Patients who have sedentary life style will be advised those to walk at most 30 minutes for 5 days in a week. physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. (inactive category [<600 MET-min/week] according to the IPAQ classification)
Period Title: Overall Study
STARTED 42 39 39
COMPLETED 35 35 35
NOT COMPLETED 7 4 4

Baseline Characteristics

Arm/Group Title Group 1 Group 2 Sham-controlled Total
Arm/Group Description Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand) dapoxetine 30 mg on demand: Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week Patients who have sedentary life style will be advised those to walk at most 30 minutes for 5 days in a week. physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week Total of all reporting groups
Overall Participants 35 35 35 105
Age (Count of Participants)
<=18 years
0
0%
0
0%
0
0%
0
0%
Between 18 and 65 years
35
100%
35
100%
35
100%
105
100%
>=65 years
0
0%
0
0%
0
0%
0
0%
Sex/Gender, Customized (Count of Participants)
Male
35
100%
35
100%
35
100%
105
100%
Race and Ethnicity Not Collected (Count of Participants)
Count of Participants [Participants]
0
0%
Region of Enrollment (count of participants) [Number]
Turkey
35
100%
35
100%
35
100%
105
100%

Outcome Measures

1. Primary Outcome
Title Premature Ejaculation Diagnostic Tool (Total Score)
Description Premature Ejaculation Diagnostic Tool (PEDT) includes five items; control, frequency, minimal stimulation, distress, and interpersonal difficulty. In this classification tool, equal to or less than scores 8 indicates no PE, scores 9 and 10 indicate possible PE, and scores equal or higher than 11 indicates PE. Total score is between 2 and 22.
Time Frame Baseline and 30 Days

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Group 1 Group 2 Sham-controlled
Arm/Group Description Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand) dapoxetine 30 mg on demand: Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. Physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week (To increase the physical activity level to "minimally active category or moderate physical activities [600-3,000 MET-min/week] according to IPAQ classification) Patients who have sedentary life style will be advised those to walk at most 30 minutes for 5 days in a week. physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. (inactive category [<600 MET-min/week] according to the IPAQ classification)
Measure Participants 35 35 35
baseline data
14.5
(1.9)
13.7
(1.8)
13.7
(2.2)
end of study data
8.9
(2.5)
7.8
(2.9)
12.8
(1.7)
2. Primary Outcome
Title Intravaginal Ejaculatory Latency Time
Description Duration determined by the sexual partner with stopwatch method, and <1 minute was considered as PE. (minimum/maximum scores were not possible)
Time Frame Baseline and 30 Days

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Group 1 Group 2 Sham-controlled
Arm/Group Description Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand) dapoxetine 30 mg on demand: Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. Physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week (To increase the physical activity level to "minimally active category or moderate physical activities [600-3,000 MET-min/week] according to IPAQ classification) Patients who have sedentary life style will be advised those to walk at most 30 minutes for 5 days in a week. physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. (inactive category [<600 MET-min/week] according to the IPAQ classification)
Measure Participants 35 35 35
baseline data
36.8
(13.1)
39.3
(8.8)
33.8
(14.7)
end of study data
181.7
(88.8)
188.6
(82.9)
50.3
(19.1)

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Group 1 Group 2 Sham-controlled
Arm/Group Description Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand) dapoxetine 30 mg on demand: Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week Patients who have sedentary life style will be advised those to walk at most 30 minutes for 5 days in a week. physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week
All Cause Mortality
Group 1 Group 2 Sham-controlled
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/35 (0%) 0/35 (0%) 0/35 (0%)
Serious Adverse Events
Group 1 Group 2 Sham-controlled
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/35 (0%) 0/35 (0%) 0/35 (0%)
Other (Not Including Serious) Adverse Events
Group 1 Group 2 Sham-controlled
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/35 (0%) 0/35 (0%) 0/35 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Muhammet Fatih Kilinc
Organization Ankara TRH
Phone +90 312 595 3700 ext 3724
Email mdfatihkilinc@yahoo.com
Responsible Party:
Muhammet Fatih Kilinc, M.D., Ankara Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT02844998
Other Study ID Numbers:
  • 5191
First Posted:
Jul 26, 2016
Last Update Posted:
Sep 29, 2017
Last Verified:
Sep 1, 2017